CME Sues CFTC to Reclassify Kalshi's Bitcoin Perpetual Futures as Swaps, Not Futures

Since the CFTC approved regulated crypto perpetual futures earlier this month, the incumbents have moved to fight back in court.

CME Group, the dominant U.S. derivatives exchange, sued the CFTC over its approval of Kalshi's Bitcoin perpetual futures contract. The suit was filed June 18, 2026, according to reporting by David Christopher via Bankless.com, republished at ZeroHedge. The CFTC responded the same day, calling the suit "frivolous" and saying it looks forward to dismissing it.

What CME Is Actually Arguing

CME is NOT asking the court to ban perpetual futures.

CME wants the product reclassified from a futures contract to a swap. The distinction is everything. Futures contracts can trade on regulated futures exchanges accessible to ordinary U.S. retail customers. Swaps fall under a heavier regulatory framework designed primarily for institutional counterparties, making them harder to distribute and functionally out of reach for most individual traders.

In plain terms: reclassify the product as a swap, and Kalshi can't offer it to retail users in its current form. The ban CME wants is a ban by paperwork, not by prohibition.

Why This Threatens CME's Business

A standard futures contract expires. When a trader wants to maintain the same exposure past the expiration date, they have to roll into a new contract, and CME collects another round of trading and clearing fees on that transaction. It's a recurring revenue mechanism built into the product structure itself.

Perpetual futures don't expire. A trader can hold the same position indefinitely without rolling. CME collects no roll fees.

For a company whose dominance in U.S. derivatives has made it one of the most profitable exchanges in the world, that's a structural threat. Bankless.com characterized CME's filing as safety language wrapped around a financial motive, writing that "perps threaten the part of CME's business built around expiration."

Attorney Jake Chervinsky put it more bluntly on X on June 18: "CME is scared of perps. No one should be scared of CME."

The Strongest Case for CME's Position

It's fair to take CME's legal argument seriously on its own terms before dismissing it as rent-seeking.

The futures/swap distinction isn't invented for this lawsuit. It's a statutory line Congress drew in Dodd-Frank, and courts and regulators have spent years litigating exactly where specific products fall. Perpetual futures are genuinely novel instruments that don't map cleanly onto existing categories. They have features that arguably resemble swaps more than traditional term futures. If the CFTC approved Kalshi's product by shoehorning it into a regulatory category that doesn't quite fit, a court challenge is a legitimate mechanism for resolving that ambiguity. CME's concern isn't inherently anti-competitive just because the company also benefits from the outcome.

The CFTC's approval process, and whether it applied the correct statutory framework, is a real legal question that a federal court is now positioned to answer.

CME and ICE's Broader Pattern

This lawsuit didn't come out of nowhere. According to Bankless.com's reporting, CME and ICE have both been pressing regulators to scrutinize decentralized exchange Hyperliquid for alleged manipulation, sanctions evasion, and related concerns as perpetual futures have grown in global volume. The pattern suggests a coordinated effort to use regulatory process as a competitive tool, though no formal finding of bad faith has been made against either company.

That context matters. Regulators should be responsive to legitimate market integrity concerns. They should be skeptical when the entities raising those concerns are also the ones who profit most from their competitors being constrained.

What Happens Next

Kalshi and Kraken have already launched regulated perpetual crypto futures products in the U.S. following the CFTC's approval. CME's lawsuit doesn't automatically pause those products. It asks a federal court to intervene. Whether the court grants any injunctive relief while the case proceeds is the first concrete question with a real deadline.

If CME wins the classification argument, regulated retail access to crypto perps in the U.S. gets substantially narrowed, and the existing compliant launches by Kalshi and Kraken face an uncertain future. If the CFTC prevails, the incumbent exchange model faces a permanent structural competitor it cannot regulate away.